BRCA Patients and Clinical Collectives: New Configurations of Action in Cancer Genetics Practices
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Since the late 1980s, in France and in a number of other countries, cancer genetics testing has become a clinical reality, particularly for hereditary breast and ovarian cancer. BRCA tests allowing for the assessment of an increased cancer risk among patients and their healthy relatives are now being routinely performed as part of clinical practice. Based on fieldwork on French clinical cancer genetics and on the French Cancer Genetics Collaborative Network, this paper examines the configuration of entities, actors and activities mobilized by the performance of BRCA testing, and argues that the development of clinical molecular genetic practices is predicated upon the development of new forms of collaborative work that lead to a transformation of the content and organization of medical activities and judgements. The paper analyses three major collective configurations - local multidisciplinary collectives, data collectives and new clinical collectives - and argues that they not only provide the material conditions needed to carry out the relevant activities, but also articulate a series of distinctive bio-clinical interventions. These interventions provide an interface with research activities, produce the epidemiological measurements and tools that are a sine qua non for clinical work in this field, and, most importantly, establish the conventions that underlie practices, which define the criteria that turn tools and novel entities into operational components of clinical settings. It thus appears that in the field of clinical cancer genetics, bioclinical collectives, as a locus of expertise, have replaced the individual judgement of the practicing clinician.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence based medicine: what it is and what it isn't
Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996) · BMJ · doi:10.1136/bmj.312.7023.71 · Cited by 15,769
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680 · cited 2×
“…the presence of a mutation and the actual development of a cancer is not well known: ‘Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is uncertain and may depend on the context’ (Antoniou et al., 2003; emphasis added).”
BackgroundRisks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850 · cited 2×
“The 80% risk figure mentioned by the clinician in this excerpt was based on early studies (Ford et al., 1994) and has been questioned by more recent studies.”
Result
Cited by
Regulatory objectivity and the generation and management of evidence in medicine
Cambrosio, A., Keating, P., Schlich, T., & Weisz, G. (2006) · Social Science & Medicine · doi:10.1016/j.socscimed.2005.12.007 · Cited by 258
The Emergence of Clinical Practice Guidelines
WEISZ, G., CAMBROSIO, A., KEATING, P., KNAAPEN, L., SCHLICH, T., & TOURNAY, V. J. (2007) · The Milbank Quarterly · doi:10.1111/j.1468-0009.2007.00505.x · Cited by 257
Invisible to Machines: Designing AI that Supports Vision Work in Radiology
Anichini, G., Natali, C., & Cabitza, F. (2024) · Computer Supported Cooperative Work (CSCW) · doi:10.1007/s10606-024-09491-0 · Cited by 18
“The assessment of cancer heritability, that includes family members, resulted in the use of the term “extended patient” (Bourret 2005).”
Cox, H., & Webster, A. (2013) · Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine · doi:10.1177/1363459312460701 · Cited by 9
Metadata
- Authors
- Bourret, P.
- Venue
- Social Studies of Science
- Publisher
- SAGE Publications
- Published
- 2005-02
- Volume
- 35
- Issue
- 1
- Pages
- 41-68
- ISSN
- 0036-8539 (ISSN-L)
- 0306-3127
- 1460-3659
- OpenAlex
- W2108613868
- Cited by
- 94
- References
- 3
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.